University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million Series B funding round. The funding will help propel the… Read More
The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valerie Daggett spoke… Read More
Researchers at the University of Washington have created a molecule that aims to stop the formation of protein clusters thought to be a prime contributor to Alzheimer’s disease. In a… Read More